您当前的位置:
首页 >
文章列表页 >
Experimental study on Gutongling Prescription combined with zoledronic acid in treating bone metastasis of lung cancer based on Blimp1/Bcl6 pathway
更新时间:2022-08-31
    • Experimental study on Gutongling Prescription combined with zoledronic acid in treating bone metastasis of lung cancer based on Blimp1/Bcl6 pathway

    • Shanghai Journal of Traditional Chinese Medicine   Vol. 52, Issue 12, Pages: 84-89(2018)
    • DOI:10.16305/j.1007-1334.2018.12.022    

      CLC:

    扫 描 看 全 文

  • LUO Qinqin, XU Zhenye, XUE Sha. Experimental study on Gutongling Prescription combined with zoledronic acid in treating bone metastasis of lung cancer based on Blimp1/Bcl6 pathway. [J]. Shanghai Journal of Traditional Chinese Medicine 52(12):84-89(2018) DOI: 10.16305/j.1007-1334.2018.12.022.

  •  

0

Views

251

下载量

0

CSCD

3

CNKI被引量

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Effects of Gutongling Prescription on the pain behavior in mice model of lung cancer with bone metastasis and MCP-1 and NGF in the spinal cord
Yin-Yang property of osteoblast and osteoclast in bone homeostasis

Related Author

No data

Related Institution

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
University of Alabama at Birmingham
Spine Research Institute, Shanghai University of Traditional Chinese Medicine
Research Institute of Shi Xiaoshan in Shanghai, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
0